|Day Low/High||138.76 / 143.86|
|52 Wk Low/High||125.84 / 197.00|
This will be the craziest reporting season we've seen in ages, says Jim Cramer. He's got your game plan for next week.
A three-year decline in the shares of the maker of Botox will take more than a two-week bounce to reverse.
Plus: Jim Cramer interviews Apple CEO Tim Cook about innovation, investments and healthcare technology.
The RMPIA index was up for the year, while the S&P 500, DJIA, Russell 2000 and Nasdaq all finished 2018 in the red.
- These initial data show the potential for the vast majority of patients to remain treatment free for at least 1 year -
- The facility, located in Kendall Square, is expected to open in 1Q2019 -
NEW ORLEANS, Jan. 4, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C.
Preclinical research demonstrated rapastinel positively modulates the NMDA receptor
DUBLIN, Jan. 3, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced it intends to release fourth quarter and full year 2018 financial results on Tuesday, January 29, 2019, prior to the open of U.
DUBLIN, Dec. 24, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37 th Annual J.
BOSTON, Dec. 21, 2018 /PRNewswire/ -- Block & Leviton LLP ( www.
When I looked at the charts this morning I found a stock that could still decline further.
Buying stocks now means you are in the uncomfortable position of fighting the Fed as it tries to slow the economy.
These are currently situations where companies are facing serious lawsuits.
NEW YORK, Dec. 19, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Allergan plc ("Allergan" or the "Company") (NYSE: AGN) (ISIN: IE00BY9D5467).
Allergan's textured breast implants have been linked to a rare form of cancer.
- Action Being Taken Following CE Mark Expiration and Compulsory Recall Request by Agence Nationale de Sécurité du Médicament (ANSM) - DUBLIN, Dec.
The CEOs who bring in the most money every year may not be who you expect. Who are the highest-paid CEOs?
At today's Analyst and Investor Conference hosted in New York, CEO Alex Wynaendts and Aegon's US management team will outline how targeted actions to simplify and grow the business are creating significant value for all stakeholders.
Still, there were some bullish aspects to the action today much as you might think otherwise.
We'll be out later with key thoughts from our discussion on what direction the portfolio should be taken as we quickly approach a new investment year.
-- Daphne Karydas named Senior VP, Corporate Financial Planning & Analysis and Strategy --
DUBLIN, Nov. 20, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the 2018 Citi Global Healthcare Conference in New York...
- Application Seeks to Expand the AVYCAZ label to Include Treatment of cUTI and cIAI in Pediatric Patients 3 months of age and older -
Aegon today announces that its subsidiary in the United Kingdom has strengthened its existing partnership with Atos, signing a 15-year contract to service and administer its Existing Business (non-platform customers).
Aegon's Supervisory Board will propose to the Annual General Meeting of Shareholders in May 2019 to reappoint Alex Wynaendts (58) as Chief Executive Officer of the company, for a four-year term.
Let's check the charts and technical indicators for some guidance.
Jim Cramer's been saying that that if the Fed or the president blink in their wars against inflation and China you could have an up day. That's what we got.
Once the safest stocks in the book, the big-cap drug companies are now toxic.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.